USA grapples with high drug costs

Lancet. 2015 Nov 28;386(10009):2127-8. doi: 10.1016/S0140-6736(15)01098-3.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval
  • Drug Costs*
  • Drug Discovery
  • Economic Competition
  • Humans
  • United States